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Summary The intensity and degree of heterogeneous epithelial marker expression were evaluated
immunohistochemically in 29 mucosal biopsy specimens from 7 ulcerative colitis (UC) patients with dysplasia.
Biopsy specimens from UC patients with mild (n=7) or severe (n=6) inflammation and from histologically
normal samples (n=7) served as controls. HLA-DR showed heterogeneous epithelial expression in all lesions
with high grade dysplasia and in 6 of 8 with low grade dysplasia. SC was heterogeneously stained in 17 of 21
lesions with high grade dysplasia and in all but two lesions with low grade dysplasia. In histologically normal
mucosa, SC was homogeneously expressed and epithelial DR was virtually absent. In mildly inflamed UC
lesions, SC exhibited patchy distribution in only one sample and DR in two, whereas both SC and DR
showed a slight degree of heterogeneous expression in all lesions with severe inflammation. Moreover, the
overall intensity of SC staining tended to decrease with increasing degree of inflammation, whereas the
opposite was seen for DR. Decreased SC and increased DR expression thus seemed to be related to
intensified inflammatory activity, whereas heterogeneous expression of these markers was significantly more
related to dysplasia.
Patients with long-standing total ulcerative colitis (UC) are
at increased risk for developing large bowel carcinomas
(Lennard-Jones et al., 1983). It is generally accepted that this
risk is related to high grade epithelial dysplasia. All patients
with long-standing UC should be subjected to regular biopsy
sampling from the various segments of the large bowel to
select those who would benefit from prophylactic procto-
colectomy (Vatn et al., 1984).
Epithelial dysplasia of the large bowel epithelium is often
difficult to evaluate because inflammation and crypt
destruction result in regenerative alterations which may
imitate those found in genuine dysplasia (Riddel et al.,
1983). Many attempts have been made to find markers of a
truly dysplastic development, but conclusive evidence to this
end has yet to be presented (Issacson, 1976; 1982; Rognum et
al., 1982a; Boland et al., 1984; Hammarberg et al., 1984;
Shields et at., 1985; Ehsanullah et al., 1985; Jass et al., 1986).
It seems justified to continue the search for objective
criteria of dysplasia. The purpose of the present investigation
was to evaluate epithelial expression of class II (HLA-DR)
determinants and secretory component (SC) in lesions of UC
by means of immunohistochemistry. The idea was that
phenotypic characteristics might reflect genotypic alterations
typical for dysplastic epithelium.
Materials and methods
Patients and tissue samples
Forty two colonic biopsy specimens from 13 patients with
long-standing ulcerative colitis were examined immunohisto-
chemically with regard to epithelial expression of HLA-DR
determinants and SC. The mucosal specimens were taken at
random, but well away from the tumour in cases with
carcinoma. Clinico-pathological information about these
patients is given in Table I.
Seven biopsy samples from 5 patients with endoscopically
and histologically normal large bowel mucosa served as
controls. Their median age (three men and two women) was
48 yr. They underwent colonoscopy because of family
investigations for polyposis coli or they had abdominal
complaints.
Correspondence: T.O. Rognum.
Received 26 January 1987; and in revised form, 6 May 1987.
Immunohistochemical procedures
The tissue specimens were fixed in cold 96% ethanol and
processed for paraffin embedding as described previously
(Brandtzaeg, 1974). Serial sections (6 um) were dewaxed and
subjected to paired immunofluorescence staining at room
temperature. One section from each series was stained by a
trichrome routine method (HAS) containing haematoxylin,
azofloxine, and safron (Stave & Brandtzaeg, 1977). Another
section was first incubated for 30 min with a tetramethyl-
rhodamine isothiocyanate (TRITC)-labelled sheep IgG anti
SC; its optical density (OD) ratio (280nm/SlSnm) was 1.7
and its working concentration 0.64g IgG1 - (Rognum et al.,
1980). Thereafter a murine monoclonal antibody to a
nonpolymorphic HLA-DR determinant (Beckton Dickinson,
Sunnyvale, Calif., USA) was applied (1:20 for 20 h) in a
three-step immunofluorescence method (Brandtzaeg &
Rognum, 1983) including specific biotinylated horse anti-
mouse IgG (0.05 g IgG 1- 1, 3 h) and fluorescein isothio-
cyanate (FITC)-labelled avidin (0.05 g1-1, 30min), both
purchased from Vector Laboratories (Burlingame, Calif.,
USA). The staining procedure is schematically depicted in
Figure 1.
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Figure 1 Schematic illustration of the paired immuno-
fluorescence staining method used for simultaneous
demonstration of HLA-DR determinants and secretory
component (SC).
Evaluation oJ immunofltuorescence staining
Observations were perlformed in a Leitz Orthoplan
fluorescence microscopc equipped with an Osram HBO
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200W lamp for excitation of TRITC (red emission) and with
an XBO 150W lamp for FITC (green emission). Narrow-
band excitation and selective filtration of the fluorescence
colours were obtained with a Ploem-type epi-illuminator.
The epithelial staining for HLA-DR and SC was scored
semiquantitatively on arbitrary scales from 0 to 3. DR-
positive cells showed usually diffuse fluorescence throughout
the cytoplasm with peripheral intensification, particularly
apically in glandular structures. A score of 0 was given for
virtually no staining, I for faint peripheral staining with
extension into the cytoplasm, and 3 for intense overall
fluorescence. Details about the scoring of SC staining are
given elsewhere (Rognum et al., 1980). The same investigator
was responsible for the fluorescence evaluation throughout
the study without knowing the histological diagnosis. A
blind test for reproducibility in a previous study did not
reveal any systematic error (Rognum et al., 1980).
The distribution of the SC and DR staining was, in
addition, separately categorized as heterogeneous (extensive,
intermediate or slight) or homogeneous. An extensive degree
of heterogeneous staining refers to the presence of abrupt
transition between positive and negative epithelium (Rognum
et al., 1982b, 1983).
The adjacent HAS-stained sections were evaluated blindly
by another pathologist throughout the study. Dysplasia was
graded as high-grade or low-grade according to the
standardized classification of Riddell et al. (1983). Biopsy
samples showing overt inflammation, crypt destruction and
epithelial regeneration were not evaluated with regard to
dysplasia (Yardley & Keren, 1974). The degree of
Table I Clinico-pathological information on the
colitis
Patient
no.
2
3
4
5
6
7
8
9
10
11
12
13
Age Sex
33
39
30
35
17
35
22
17
14
21
49
48
20
F
F
M
M
F
F
M
M
M
M
M
M
M
9
24
13
19
8
10
16
7
5
3
15
15
10
high
high
high
high/low
high/low
low
low
inflammatory changes in biopsy samples without dysplasia
was graded as severe or mild.
Statistical analyses
Comparisons between sample groups with regard to
fluorescence scores and degree of heterogeneous expression
were based on the one-tailed Mann-Whitney U test.
Results
High grade dysplastic lesions were found in 21 biopsy
samples, whereas 8 were assigned to the low grade dysplasia
group. Seven biopsy samples with regenerative changes
showed a mild degree of inflammation whereas six showed a
severe degree (Table I).
In normal large bowel mucosa the staining for SC was
evenly distributed throughout the columnar epithelial cells
with intensification along the luminal border, whereas there
was virtually no or only very faint staining for HLA-DR
determinants (Figures 2, 5 and 6).
In the group of samples with inflammatory changes (but
with no sign of dysplasia) the staining intensity for SC
tended to decrease with increasing degree of inflammation
whereas the opposite was noted for HLA-DR (Figures 3 and
5).
A slight degree of heterogeneous staining was seen for
both epithelial markers in approximately half of the lesions
with regenerative changes - mostly in the group with severe
patients with longstanding ulcerative
severe
severe
severe
severe/mild
severe/mild
mild
Sigmoid flexure
Ascending colon
Descending colon
Caecum
No
Caecum
No
No
No
No
No
No
No
"Samples with overt
dysplasia; see text.
inflammatory alterations were not evaluated with regard to
Figure 2 Endoscopically normal colonic mucosa. The same section was stained (a) green for HLA-DR determinants and (b) red
for secretory component (SC). The epithelium is virtually negative for HLA-DR, whereas SC is evenly distributed throughout the
columnar epithelial cells. Note numerous DR-positive cells in the lamina propria ( x 80).
Duration of Grade of Severity of Development of
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Figure 3 Colonic mucosa with regenerative changes due to inflammation. The same section was stained (a) green for HLA-DR
determinants and (b) red for SC. The columnar epithelial cells are evenly positive for both markers ( x 115).
Figure 4 Colonic mucosa with high-grade epithelial dysplasia. The same section was stained (a) green for HLA-DR determinants
and (b) red for SC. The epithelial expression of HLA-DR is heterogeneous, being absent in some of the glands (left), whereas SC
is relatively evenly distributed. Note numerous DR-positive cells in the lamina propria ( x 15).
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Figure 5 Colonic mucosa with high-grade epithelial dysplasia. The same section was stained (a) green for HLA-DR determinants
and (b) red for SC. Both markers are virtually absent in parts of the epithelium. Note numerous DR-positive cells in the lamina
propria ( x 115).
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Figure 6 Scatter diagram of epithelial staining for secretory
component and HLA-DR determinants in normal and inflamed
colonic mucosa. Columns indicate median fluorescence scores.
Inflamed mucosa showed significantly less SC (P- 0.05) and
more epithelial HLA-DR expression (P<0.01), than normal
mucosa. Samples with severe inflammation showed less SC
(PO0.05) and more HLA-DR expression (P<0.02) than those
with mild inflammation.
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Figure 7 Scatter diagram of degree of heterogeneous expression
of secretory component and HLA-DR determinants in normal
colonic mucosa and ulcerative colitis lesions with various degrees
of inflammation or dysplasia. Both SC and HLA-DR staining
was significantly (P<0.0001) more heterogeneous in dysplastic
lesions than in those with merely inflammatory changes.
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inflammation (Figure 7). Dysplastic lesions showed
heterogeneous expression of SC in all but six biopsy samples
and all but two showed heterogeneous expression of HLA-
DR antigens (Figures 4, 5 and 7). High grade dysplastic
lesions, in fact, always showed heterogeneous staining for
DR, and in all except two the heterogeneity was extensive or
intermediate (Figure 7).
Discussion
Although dysplasia as judged by conventional
histopathological methods is found in most UC patients who
undergo colectomy for carcinoma, it successfully predicts
carcinoma in only about 60% of UC patients who are under
surveillance (Lennard-Jones et al., 1983). It is important,
therefore, to search for more sensitive and reliable markers
for detecting a neoplastic development.
A variety of epithelial features have been suggested to this
end, but so far none appears to be of clinical interest. CEA
expression is irrelevant because it occurs in both regenerative
and neoplastic lesions (Rognum et al., 1982a). The presence
of sulphated mucopolysaccharides, binding of peanut
agglutinin or differences in the nuclear DNA content have
likewise turned out to be of no diagnostic value (Jass et al.,
1986; Hammarberg et al., 1984). Furthermore, a significantly
weaker expression of SC in dysplastic compared with
regenerative lesions is not applicable in diagnostic work
because of large individual variations (Rognum et al.,
1982a).
In the present study we showed that dysplastic lesions
expressed both HLA-DR and SC in a more heterogeneous
pattern than those with regenerative epithelial changes.
Extensive heterogeneity was seen especially in high-grade
dysplasia and might be due to the presence of several
different neoplastic cell clones with variable ability to express
the two epithelial markers. Such phenotypic differences
between clones within the same lesion might reflect early
cancer development as proposed by Nowell (1976; 1986).
According to his theory, tumour progression is explained by
an acquired genetic lability permitting increasingly altered
subpopulations with new characteristics. In this context it is
interesting that the HLA-DR expression in dysplastic UC
lesions resembled that seen in well-differentiated large-bowel
carcinomas (Rognum et al., 1983).
The increase in HLA-DR expression noted with increasing
degree of inflammation was in accordance with previous
findings (Selby et al., 1983; Poulsen et al., 1986; Moore et
al., 1986; McDonald & Jewell, 1987). Such aberrant DR
expression might reflect immunological activity since DR
production may be induced by y-interferon - a lymphokine
released from activated T-cells (Pober et al., 1983).
Moreover, the evenly distributed expression of both DR and
SC in UC without dysplasia, was similar to that seen in the
'transitional mucosa' adjacent to carcinomas (Rognum et al.,
1982c; 1983; Moore et al., 1986). This might be of interest as
the mucosa in this zone, as in the UC lesions, contains dense
infiltrates of lymphoid cells and macrophages (Svennevig,
1980; Rognum et al., 1979).
SC expression in ulcerative colitis was significantly reduced
compared with normal (Rognum et al., 1982a), and tended
to decrease with increasing inflammatory activity. This
finding might seem to contrast with the observations of y-
interferon-induced SC expression in a colon carcinoma cell
line (Sollid et al., 1987) and of increased SC expression in
inflammatory lesions in gastric mucosa (Valnes et al., 1984)
and salivary glands (Thrane et al., personal communication).
However, in UC the secretory epithelium may be under
particular influence by as yet undefined factors which lead to
down-regulation of SC expression. Moreover, decreased SC
expression does not necessarily imply impaired production
but may reflect enhanced secretion rate (Hamilton et al.,
(1980).
Since samples showing overt inflammatory changes were
not evaluated with regard to dysplasia (Yardley & Keren,
1974), we believe that the observed heterogeneous expression
of HLA-DR might reflect epithelial genotypic heterogeneity
rather than varying microenvironmental influences on the
epithelium. The similarities in distribution pattern of DR
determinants in dysplastic UC lesions and in most large
bowel carcinomas (Daar et al., 1982,1983; Rognum et al.,
1983; Ghosh et al., 1986; Moore et al., 1986), indicate that
this feature is phenotypic for early malignant development in
large bowel epithelium. This hypothesis is further
strengthened by the observation that similar heterogeneity is
seen in large bowel adenomas (Rognum et al., unpublished
observation). The possibility that the present finding might
turn out to be helpful in a diagnostic context remains to be
tested in a larger, prospective follow-up study.
This study was supported by the Norwegian Cancer Society.
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